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Introduction
Acetyl-N-Ser-Asp-Lsy-Pro (AcSDKP) is a tetrapeptide that is 
naturally released in organisms from its metabolic precursor 
thymosin β4 by prolyloligopeptidase (POP), a serine 
proteinase found in mammalian tissue.1 It has been for years 
regarded as a physiological negative regulator of  proliferation 
of  haematopoietic stem cells and committed haematopoietic 
progenitors cells. It acts by blocking haematopoietic stem 
cells from being recruited from G0 or early G1 to enter into 
S phase. This mechanism of  blocking the transition from 
G0 to S phase of  the haematopoietic stem cell cycle keeps 
haematopoietic stem cells in the quiescent phase.2,3 Further 
studies have shown that AcSDKP regulates cell survival 
through the PI3KCA/Akt pathway.4 It is now also regarded 
as an angiogenesis factor.5 In normal physiology, AcSDKP 
is observed in higher titres and is thought to work best in 
concentrations below 10-7 M and above 10-14 M.6 Since it 
is highly implicated in haematopoiesis and angiogenesis, 
AcSDKP has been studied in a number of  conditions and 
disorders of  the blood and the bone marrow systems.
In neoplastic diseases, including haematological malignancies 
and solid neoplasms, studies have revealed elevated levels 
of  endogenous AcSDKP.7,8 In leukaemia-inoculated mice, 
endogenous AcSDKP concentration has been shown to 
dramatically increase.9 High levels of  AcSDKP have also 
been demonstrated in different solid human malignancies.10 
In chronic kidney disease, accumulation of  AcSDKP has 
been associated with the exacerbation of  anaemia, though 
AcSDKP levels have been shown to decrease in patients 
with end-stage renal disease after kidney transplantation.11 
The importance of  AcSDKP in anaemic conditions cannot 
be overemphasised.
To the best of  our knowledge, there are no studies that have 
examined the levels of  AcSDKP in trypanosoma-induced 
anaemia. Although a number of  studies have documented 
the ability of  trypanosomes to produce negative regulatory 
cytokines in vivo and in vitro, to date there has been no study that 
has associated AcSDKP with trypanosomiasis or indicated 
any link between AcSDKP and haematopoietic stem cell 
numbers in trypanosoma-induced anaemia. In order to get 
further insight into the mechanisms behind the pathogenic 
events occurring in trypanosomiasis, AcSDKP was studied 
together with interleukin-10 (IL-10), which is a cytokine that 
is known to suppress the production of  other cytokines. 
IL-10 is a type II anti-inflammatory cytokine, produced by 
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Anaemia commonly results from destruction of  erythrocytes in the peripheral blood and failure of  the bone marrow haematopoietic 
cells to replenish the erythrocytes. The mechanisms involved in trypanosoma-induced anaemia, including the role of  the bone 
marrow haematopoietic cells are incompletely understood. We studied the responses of  a tetrapeptide, AcSDKP, and IL-10, and their 
association with bone marrow nucleated cells in a Trypanosoma brucei brucei GVR35 experimental infection model.
Methods
Mouse infection was done intraperitoneally with 1 × 103 trypanosomes/mL. Mice were either infected or left uninfected (N = 100). 
At days 0, 9, 16, 23, 30, 37, and 44 post-infection, mice were euthanised and blood was collected by cardiac puncture to examine for 
parasitaemia and packed cell volume (PCV) and then centrifuged for plasma, which was used for cytokine ELISA. The mice’s femurs 
were also dissected and bone marrow was collected for femur cellularity.
Results
PCV dropped from 39.6% to 27% in infected animals by day 9 and remained low (relative to uninfected mice) for the duration of  
the experiment. AcSDKP levels decreased from day 0 (11.5 × 104 pg/mL) to day 16 (10 × 104), and increased by day 30 (12.6 × 104). 
There was a significant difference at day 16 (P = 0.023) between the infected and uninfected groups. By contrast, expression of  IL-10 
markedly increased between day 0 (18.6 pg/mL) and day 16 (145 pg/mL) and decreased by day 30 (42.8 pg/mL). There was also a 
significant difference in IL-10 expression between infected and uninfected mice at day 16 (P < 0.001). Bone marrow nucleated cells 
were significantly reduced during periods of  low plasma AcSDKP and high plasma IL-10 concentrations (5.4 × 106 infected vs 6.2 × 
106 on day 0 and 4.9 × 106 infected vs 10 × 106 uninfected on day 16).
Conclusions
These data unravel a possible negative feedback interaction between AcSDKP and IL-10 in trypanosome infection. More importantly, 
this study implicates an IL-10/AcSDKP cytokine network in the regulation of  bone marrow nucleated cells and provides a new 
potential mechanism in the pathogenesis of  trypanosoma-induced anaemia. Further mechanistic blocking experiments on AcSDKP 
and IL-10 are recommended to further clarify understanding of  the interaction.
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Th2 T-helper cells. This study investigated AcSDKP levels 
and IL-10 levels, in an experimental mouse model during 
anaemia induced by Trypanosoma brucei infection, in relation 
to the number of  nucleated cells in the bone marrow.
Methods
Trypanosomes
Trypanosoma isolate T.b. brucei strain GVR35 was obtained 
from the Makerere College of  Veterinary Medicine and 
Animal Resources and Biosecurity (COVAB) immunology 
laboratory. This parasite was originally isolated from the 
bloodstream of  infected wildebeest in the Serengeti in 
1966 (Serengeti/66/svrp/10).12 T.b. brucei stabilates were 
kept frozen in liquid nitrogen and an aliquot was passaged 
through Wistar rats before the experiments were carried out. 
Stabilates were made by preserving 1 in 3 parts of  blood 
containing the parasite with 30% glycerol–phosphate buffer 
saline with glucose (PSG).
Experimental mice
Female Swiss albino mice were purchased from the Uganda 
Virus Research Institute (UVRI) Animal House (Entebbe, 
Uganda) at 8 to 12 weeks old. All mice were housed at the 
COVAB animal facility under standard laboratory conditions 
according to the university’s recommendations for animal 
care. The mice were maintained on a diet of  commercial 
mouse pellets (Engaano Millers Ltd, Kampala, Uganda) with 
access to clean water ad libitum.
Mice were infected by intraperitoneal inoculation of  1 × 
103 trypanosomes/mL. Mice were either infected or left 
uninfected as controls. A total of  100 mice were used, with 
5 mice starting each time point. At days 0, 9, 16, 23, 30, 37, 
and 44 post-infection, mice were euthanised and blood was 
collected by cardiac puncture to examine for parasitaemia and 
packed cell volume (PCV). The blood was then centrifuged 
in EDTA tubes for 10 minutes at 1280 g to collect plasma. 
Centrifugation separates the blood into 3 layers: the red 
blood cell (RBC) layer, which sets at the bottom of  the tube; 
followed by the buffy coat (composed of  white blood cells 
and platelets); and the plasma layer on top. Plasma was then 
carefully removed using pasture pipettes and was kept frozen 
at -80°C for evaluation of  cytokines using an enzyme-linked 
immunosorbent assay (ELISA) technique. Additionally, cells 
were flushed from the mice’s dissected femurs for evaluations 
of  femur cellularity.
Cell isolation
Bone marrow was flushed from the femurs under the 
sterile condition in a laminar flow hood (Aura vertical 
S.D.4, BIOAIR®, Italy). The hip and knee joints were cut as 
close to the joint as possible, exposing the marrow. Using 
a 5-mL syringe (BD Bioscience) with a needle, the marrow 
was flushed from both directions with 5 mL of  ice-cold 
Roswell Park Memorial Institute (RPMI) 1640 medium with 
L-glutamine (BioWhittaker®Lonza, Belgium) into 50-mL 
Falcon tubes (Nest®, China) until the femur colour changed 
from red to white. A single-cell suspension was achieved 
by dispersing bone marrow via suction into an empty 20-
mL syringe through a 19-mm gauge needle twice. The bone 
marrow cell suspension was washed by centrifugation (IEC 
CL31R Multispeed centrifuge, Thermo Scientific) at 320 g for 
10 minutes at 4°C. The cells were resuspended in R10 media 
made up of  RPMI 1640 with L-glutamine supplemented 
with 10% heat-inactivated foetal calf  serum (Sigma), 5 mL of  
1 M HEPES (Sigma) and 5 mL of  penicillin–streptomycin 
solution (BioWhittaker®Lonza, Belgium).
Femur cellularity
For cell counting, 20 µl of  the cell suspension was mixed with 
3% acetic acid with methylene blue, in 1:50 dilutions. Then 
10 µl of  the mixture was added into a counting slide chamber 
and mounted on a TC20TM automated cell counter (Bio-Rad, 
UK) according to the manufacturer’s recommendations. The 
cell counter gives the number of  nucleated cells per mL by 
counting the cells that pick up the blue dye. Each sample 
was counted 3 times and the means from these counts were 
recorded. Percent viability was also recorded for each sample. 
For this, 20 µl of  the sample (after cell isolation) was pipetted 
onto a Parafilm sheet and mixed with 20 µl of  trypan blue 
(1:1 dilution). Trypan blue dye 0.40% (Bio-Rad, UK) stains 
nonviable cells that have compromised membranes and was 
used to distinguish viable from nonviable. 
Bone marrow cell cultures
From the bone marrow cell suspension after cell isolation, a 
cell suspension of  concentration 106 cells/mL was removed 
from the tubes and was incubated (CO2 incubator, LEEC 
Research) at 37°C and 5% C02 for 48 hours in duplicate wells. 
After incubation, supernatant from the wells was collected 
and analysed for cytokines.
Measurement of cytokine levels
Murine cytokine and capture detection antibody against 
murine IL-10 and AcSDKP were used for sandwich 
ELISA to detect these cytokines in the plasma and cell 
culture supernatant fluids following the manufacturers’ 
recommendations. For AcSDKP (TSZ Scientific, Waltham), 
specific microtiter plates, which were commercially pre-
coated with solid-phase antibody, were used. For IL-10, 
specific (BD OptEIA) mouse IL-10 ELISA kits were used. 
Each sample of  plasma and supernatant was tested for each 
cytokine in duplicate. The detection limit for IL-10 was 30 
pg/mL; the detection limit for AcSDKP was 15 pg/mL. 
Absorbance was read at a wavelength of  450 nm using a 
microwell reader (Dynex technologies, MRX).
Statistical analysis
Levels of  cytokines were quantified and tested. Changes in 
PCV levels and nucleated bone marrow cell numbers were 
evaluated. For each variable, results were expressed as the 
mean response of  the 5 infected mice tested individually (± 
standard error of  the mean, SEM) compared with the same 
variables assessed in the 5 uninfected control mice. Evidence 
for associations between cytokines and haematological 
derangements was examined using Student’s t-test. The 
significance level was set at 0.05. Results are representative 
of  2 similar independent experiments. All data were double-
entered into a secure electronic database using GraphPad 
Prism 5.
Results
Trypanosoma infection and anaemia
Parasitaemia responses in infected and control animals are 
reported in Figure 1. In uninfected mice, no death was 
recorded. In infected mice, parasitaemia appeared by day 
9 (2.64 × 107 trypanosomes/mL [± 1.1x107]) and peaked 
by day 23 (1.3 × 108 trypanosomes/mL [± 9.9 × 107]) 
and was reduced by day 30 post-infection to 3.65 × 107 
trypanosomes/mL (± 8.3 × 106). However, the infected 
mice failed to control parasitaemia after the first wave and 
therefore experienced a high rate (90%) of  mortality during 
this period. A wave is an observed surge of  parasitaemia, 
which occurs in cycles and is moderated by host immune 
responses.
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1.5]). Anaemia was seen to be severe at day 30 post-infection 
(21% [± 1.1]) (P < 0.001). There was a significant difference 
between infected and uninfected mice (P = 0.02) over the 
entire period.
Bone marrow nucleated cells numbers during T.b. 
brucei infection
Femoral cellularity among the mice is shown in Figure 3. The 
levels of  bone marrow nucleated cells in uninfected mice 
ranged from 6.2 × 106 cells/mL (± 9.4 × 195) to 10.9 × 106 
cells/mL (± 8.2 × 105). There was a gradual increase from 
day 0 (6.2 × 106 cells/mL [± 9.4 × 105]) to day 16 (10.9 × 
106 cells/mL [± 8.2 × 105]) but thereafter it remained almost 
constant until the end of  the experiment. The mean number 
of  bone marrow nucleated cells of  infected mice decreased 
to 3.26 × 106 cells/mL (± 4.7 × 105) by day 9 (P < 0.01). 
By day 30 the bone marrow nucleated cells had increased to 
7.75 × 106 cells/mL (± 1.3 × 106). There was a significant 
difference between infected mice (3.26 × 106 cells/mL [± 4.7 
× 105]) and uninfected mice (8.7 × 106 cells/mL [± 10 × 106]) 
on day 9 (P = 0.0042) and day 16 (4.99 × 106 cells/mL [± 
5.1 × 105] and 10.9 × 106 cells/mL [± 8.2 × 105], respectively 
[P = 0.0051]). However, by day 30 the number of  nucleated 
cells in infected mice increased to levels comparable to the 
numbers in uninfected mice (7.75 × 106 cells/mL [± 1.3 × 
106] and 9.27 × 106 cells/mL [±1.5 × 106], respectively).
IL-10 and AcSDKP levels in mice during T.b. 
brucei infection
Plasma levels of  IL-10 are shown in the Figure 4. In 
uninfected mice the plasma IL-10 levels ranged from being 
undetectable to 22 pg/mL. Plasma levels of  IL-10 in infected 
mice increased from 14.67 pg/mL (± 8.7) at baseline to 145 
pg/mL (± 28.7) by day 16 and decreased to 42.8 pg/mL 
(± 8) by day 30. The lowest levels of  IL-10 were on day 30 
(42.8 pg/mL), which was significantly different to the levels 
observed in uninfected mice (6.67 pg/mL [± 1]) (P < 0.001).
Levels of  IL-10 in supernatant were analysed after 48 hours 
of  in vitro culture without physical priming with trypanosome 
(Figure 5). Cells in uninfected group could not produce IL-10 
in the supernatant. In infected animals IL-10 was expressed 
by day 16 (1644 pg/mL [± 722]) and reduced by day 30 (76 
pg/mL [± 46]) (P < 0.001).
A reduction in the cell volume (Figure 2) was observed 
among infected mice. In uninfected mice, no such reduction 
was seen and PCV ranged from 37% to 42%. In infected 
mice, PCV levels decreased early by day 9 post-infection 
(PCV dropped from 39.6% [± 0.3] pre-infection to 27.8% [± 
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Figure 1: Mean parasitaemia in mice at different time points infected with 103 parasites/ml of T.brucei GVR 35 
(black), or uninfected (green). Data (±SEM; n=5) are representative of 2 independent experiments.   
Figure 2: Packed cell volume values in mice (n = 5) at different time points infected with T.b.brucei GVR 35 
(black) or uninfected mice (green). On day 30 post-infection, the decline in the average PCV of the infected mice 
was significantly greater (p < 0.001) than in the uninfected mice.  





















Figure 2: Packed cell volume values in mice (n = 5) at different time 
points infected with T.b .brucei GVR 35 (black) or uninfected mice 
(green)
On day 30 post-infection, the decline in the average PCV of the infected mice was 
significantly greater (p < 0.001) than in the uninfected mice.
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Figure 3: Total bone marrow cellularity of mice at different time points.  Mean cellularity was significantly lower in 
infected mice than in controls Data (±SEM; n=5) are representative of 2 independent experiments. Significant 
differences between infected animals and uninfected (day 9) *P=0.0042  
 
Figure 4: Plasma IL-10 levels in mice. IL-10 was quantified in T.b. brucei  GVR 35 infected (black), and uninfected 
mice (green). Data (± SEM; n=5) are representative of 2 independent experiments. Significant difference between 
infected and uninfected on day 16 and 30 are indicated as *P=0007 or *P<0.00001. 
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Figure 3: Total bone marrow cellularity of mice at different time 
points
Mean cellularity was significantly lower in infected mice than in controls Data (±SEM; 
n=5) are represe tative of 2 independent experiments. Significant differences between 
infected animals and uninfected (day 9) *P=0.0042
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Figure 4: Plasma IL-10 levels in mice. IL-10 was quantified in T.b. 
brucei GVR 35 infected (black), and uninfected mice (green)
Data (± SEM; n=5) are representative of 2 independent experiments. Significant 
difference between infected and uninfected o  day 16 and 30 are indicated as *P=0007 
or *P<0.00001.
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Figure 1: Mean parasitaemia in mice at different time points infected with 103 parasites/ml of T.brucei GVR 35 
(black), or uninfected (green). Data (±SEM; n=5) are representative of 2 independent experiments.   
Figure 2: Packed cell volume values in mice (n = 5) at different time points infected with T.b.brucei GVR 35 
(black) or uninfected mice (green). On day 30 post-infection, the decline in the average PCV of the infected mice 
was significantly greater (p < 0.001) than in the uninfected mice.  





















Figure 1: Mean parasitaemia in mice at different time points 
infected with 103 parasites/mL of T. brucei GVR 35 (black), or 
uninfect d (green)
Data (±SEM; n=5) are representative of 2 independent experiments.
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destruction of  the red blood cells due to cellular injury.13 
Packed cell volume (PCV) is a simple red blood cell count 
measurement that expresses the percentage of  the blood’s 
volume taken up by the red blood cells. Anaemia is said to 
start early in trypanosomiasis14 and resolves in late stage of  
the disease.15 Recovery from anaemia is characterized by 
low or absence of  parasitaemia in the blood.14 The present 
data indicates that PCV experiences sharp fall during early 
stage of  infection corresponding to the appearance of  
parasitaemia in the circulation and persists throughout the 
experiment. The anaemia did not resolve despite reduced 
levels of  parasitaemia and become severe anaemia (21%) 
after the first wave. This corresponded with high mortality 
rate of  infected animals.
Appearance of  parasitaemia in the circulation also 
corresponded to decrease in bone marrow cellularity. It has 
been reported elsewhere that in trypanosoma infection, 
the bone marrow is severely stressed by the parasite 
infection affecting the production of  mature red blood 
cells.16 Therefore it can be speculated that early reduction 
in the bone marrow cellularity observed in this study is 
an indication of  a direct trypanosome effect on the bone 
marrow cells. This speculation is justified by the fact that 
the bone marrow cellularity returned to levels almost similar 
to those of  uninfected mice after the first wave in infected 
mice. The data also implies that though parasitaemia may 
affect bone marrow cellularity at the early stage, it had little 
or no effect during the chronic phase of  the disease. 
While in infected mice PCV maintained fluctuating low levels 
throughout the course of  infection, bone marrow cellularity 
was gradually increasing. The bone marrow compartment 
seems to recover from the initial wave and this recovery 
of  bone marrow late in infection may indicate that some 
of  the haematopoietic cells may escape the effects of  the 
trypanosomes.16
A decrease in bone marrow nucleated cell numbers 
corresponded with increased IL-10 production in infected 
mice IL-10 is an intermediate acting factor that works in 
complex interactions with other cytokines in regulating 
haematopoiesis. The high levels of  IL-10 seen in association 
with low levels of  bone marrow nucleated cell numbers may 
suggest that IL-10 is part of  a cytokine cascade that affects 
the proliferation of  the bone marrow progenitors.
AcSDKP expression was observed in plasma of  both the 
infected and uninfected animals. The plasma levels observed 
in uninfected mice was consistent with literature elsewhere 
where it shows that AcSDKP is maintained in stable levels 
in normal plasma.17,18 However, the course of  AcSDKP in 
trypanosomiasis studies has not been reported before and 
here we observed that in T. brucei infected animals, AcSDKP 
was down-regulated after infection and returned to levels 
comparable to those observed at pre infection during the 
terminal stage. Though the reduced levels were observed 
with appearance of  parasitaemia, the lowest levels were 
not associated with high parasitaemia but suggest that the 
down regulation was due to the infection. Production of  
AcSDKP was not observed in bone marrow cell culture 
supernatants. Though this may mean that T. brucei failed to 
induce production of  AcSDKP in vitro, it has been reported 
that AcSDKP is degradable if  not preserved in medium such 
as captopril or lisinopril that prevents its breakdown.19 It is 
a possibility that the low undetected supernatant AcSDKP 
levels in the supernatant may be as a result of  degradation 
The normal plasma AcSDKP in uninfected group ranged 
from 11.4 × 104 pg/mL (± 2 × 103) to 13.4 × 104 (± 4 × 103) 
as shown in Figure 6. Concentrations of  AcSDKP in plasma 
from infected mice were reduced from pre-infection levels 
of  11.4 × 104 pg/mL (± 7 × 103) to 10.6 × 104 pg/mL (± 
3 × 103) on day 9 (P < 0.001). The AcSDKP concentration 
reduced further than the baseline level on day 16 to 10.1 × 
104 pg/mL (± 1.7 × 103). However, an increase of  AcSDKP 
on day 30 to 12.6 × 104 pg/mL (± 6.5 × 103) was observed (P 
< 0.01). There was significant difference between AcSDKP 
levels in infected mice as compared to uninfected mice (10.1 
× 104 pg/mL [± 1.7 × 103] vs 12 × 104 pg/mL [± 6 × 103] 
[P = 0.023]) on day 16 and on day 23 (10.4 × 104 pg/mL 
[± 2.5 × 103] vs 12.5 × 104 pg/mL [± 6 × 103] [P = 0.001]). 
However, there was no significant difference between the 
infected and uninfected mice on AcSDKP levels by day 30 
(12.6 × 104 pg/mL [± 6.5 × 103] vs 13.4 × 104 pg/mL [± 4 
x103] [P = 0.44]). 
Supernatant AcSDKP concentration in in vitro bone marrow 
cultures was not detectable. 
Discussion
Infection-induced anaemia is an important morbidity 
factor in African trypanosomiasis and has been linked to 
AcSDKP expression in trypanosomiasis 
 






















Figure 5: Supernatant IL-10 levels in mice. IL-10 was quantified in T.b.brucei GVR35 infected (black), and 
uninfected mice (green). Data (± SEM; n=5) are representative of 2 independent experiments.  




















Figure 6: Plasma AcSDKP levels in mice. At different times points, p asma levels were quantified in T.b.bru ei
GVR35 infect d (black) and uninfected mice (green) (± SEM; n=5) are representative of 2 independent experiments. 
Significant differences between infected and controls are indicated as *P=0.0230 (d y 16) or *P=0.0096 (day 23). 




Figure 5: Supernatant IL-10 levels in mice. IL-10 was quantified in 
T.b. brucei GVR35 infected (black), and uninfected mice (green)
Data (± SEM; n=5) are representative of 2 independent experiments.
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Figure 5: Supernatant IL-10 levels in mice. IL-10 was quantified in T.b.brucei GVR35 infected (black), and 
uninfected mice (green). Data (± SEM; n=5) are representative of 2 independent experiments.  




















Figure 6: Plasma AcSDKP levels in mice. At different times points, plasma levels were quantified in T.b. ruc i
GVR35 infected (black) and uninfected mice (green) (± SEM; n=5) are representative of 2 independent experiments. 
Significant differences between infected and controls are indicated as *P=0.0230 (day 16) or *P=0.0096 (day 23). 




Figure 6: Plasma AcSDKP levels in mice. At different times points, 
plasma levels were quantified in T.b.brucei GVR35 infected (black) 
and uninfected mice (green)
Data (± SEM; n=5) are representative of 2 independent experiments. Significant 
differences between infected and controls are indicated as *P=0.0230 (day 16) or 
*P=0.0096 (day 23). Differences that are not significant are indicated as •P=0.4408..
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of  the cytokine by Angiotensin Converting Enzyme 
(ACE) which degrades it using its N-terminal active site. 
Alternatively, the 48-hour period that we cultured the bone 
marrow cells probably was not long enough for the cells to 
produce an AcSDKP output that could be detectable.
Comparisons between bone marrow nucleated cells and 
expression of  AcSDKP showed that AcSDKP was down-
regulated  during the time period where there was reduction 
of  bone marrow nucleated cells. Later as the infection 
progressed towards the terminal stage, both AcSDKP and 
bone marrow nucleated cells were seen to be increasing to 
levels comparable to those observed in uninfected mice 
(Figure 3 and Figure 6). Cells in the bone marrow especially 
the haematopoietic stem cells proliferation are thought to be 
inhibited by AcSDKP as it antagonises the production of  
stimulatory factors by stromal cells. Stimulatory factors are 
important as they regulate a variety of  cell growth processes. 
Once there is disturbance in the production of  these 
stimulatory factors there is an imbalanced proportion of  high 
proliferative potential colony-forming unit (HPP-CFU-1) 
in cell cycle.20 This imbalance therefore may contribute to 
reduced numbers of  nucleated cells that could be produced 
in the bone marrow. On the other hand the increasing bone 
marrow nucleated cell numbers during the terminal stage can 
be attributed directly to the levels of   AcSDKP itself. This can 
be argued by the fact that AcSDKP was not at its optimum 
concentration therefore could not exert its inhibitory role 
on the proliferation of  stem cells. The concentration above 
10-7 M and below 10-14 M of  AcSDKP are known to have no 
effect on both mice and human bone marrow cells.6
Comparisons between IL-10 and AcSDKP cytokine 
production showed that the period when plasma levels of  
IL-10 were elevated it corresponded to the period where 
AcSDKP levels were reduced. This is not surprising as 
IL-10 is known to suppress production of  other cytokines 
that are produced by macrophages. For example, IL-10 
suppresses the production of  M-CSF, G-CSF and MIP-1αby 
macrophages21–23 which are important in the differentiation, 
proliferation and maturation of  cells. AcSDKP has also been 
shown to be produced by macrophages in vitro24 bringing 
the possibility that there could be an indirect inhibition 
of  stimulatory molecules on this macrophages by IL-10 
to produce AcSDKP. Due to suppressive nature of  IL-10 
on immune processes, it is plausible then that it may also 
suppress AcSDKP production, but this needs to be further 
investigated.
Interestingly on day 30 while low levels of  plasma IL-10 
were observed, AcSDKP was up-regulated postulating the 
idea that the level of  IL-10 reflects the proceeding AcSDKP 
response which suggests  a counter balance between IL-
10 and AcSDKP towards improving survival of  the host. 
However, this study did not measure this mechanistic 
response between AcSDKP and IL-10 and we suggest 
further studies to look into this aspect.
Conclusions
AcSDKP was seen to be lowered from its normal 
physiological levels during the presence of  high IL-10 in 
trypanosome induced anaemia. In normal body physiology 
AcSDKP is observed in high titres and IL-10 is normally low 
or undetected. We have also observed an increase in bone 
marrow nucleated cells numbers which corresponded to the 
increase of  AcSDKP concentration in the blood. Later as 
the infection progressed towards the terminal stage, both 
AcSDKP and bone marrow nucleated cells were seen to be 
increasing while IL-10 was decreasing. The IL-10/AcSDKP 
pathway needs to be further investigated.
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